by Danilo Fernandez | Oct 12, 2020 | Blog, Disease Outbreak, News
PCI FOR COVID-19 is an international, multi-site, IRB approved clinical trial created to establish an effective treatment for COVID-19, it was launched by GlobalMed Technologies USA “GMT” and partners. The PCI FOR COVID trial compares options against standard care to...
by Danilo Fernandez | Oct 12, 2019 | Funding Opportunity, News
GlobalMed Technologies USA has launched its own crowdfunding platform under Regulation D, Rule 506(c), solely directed to accredited Investors. We are leaders in the development of Photonic biomedical technologies, systems, machinery, products and multiple...
